Wir sind mit live! Mehr erfahren
UFPT-Symbol

UFP Technologies

291,67 USD
-5,52
1,86 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
Vor Börsenbeginn
Nachbörslich
291,67
0,00
0 %
1 Tag
-1,86 %
5 Tage
1,81 %
1 Monat
4,39 %
3 Monate
13,61 %
6 Monate
50,31 %
Seit Jahresbeginn
30,56 %
1 Jahr
51,12 %
5 Jahre
352,9 %
10 Jahre
1.009,01 %
 

Profil: UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Mitarbeiter: 5.349

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 46,2 %
Neutral 46,2 %
Negativ 7,7 %
Neutral
Zacks Investment Research
letzten Monat
Implied Volatility Surging for UFP Technologies Stock Options
Investors need to pay close attention to UFPT stock based on the movements in the options market lately.
Implied Volatility Surging for UFP Technologies Stock Options
Negativ
Zacks Investment Research
letzten Monat
3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes
GenAI offers growth potential for VCYT, GMED and UFPT, but regulatory and technology risks are likely to challenge adoption across healthcare.
3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes
Neutral
The Motley Fool
letzten Monat
UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares
The sale represents a total value of $324,260. The disposition was executed entirely through direct ownership, leaving the insider with 4,476 shares held directly.
UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares
Positiv
MarketBeat
letzten Monat
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds
UFP Technologies NASDAQ: UFPT outlined its strategy to expand through organic growth and acquisitions, emphasizing its role as a contract development and manufacturing organization serving medical-device companies.
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds
Neutral
Business Wire
letzten Monat
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), today announced Mitchell Rock, President and Chief Executive Officer, and Ron Lataille, Sr. Vice President, Treasurer and Chief Financial Officer, will present and host 1-on-1 meetings at the Midwest IDEAS Investor Conference on Wednesday, August 26, 2026 at The InterContinental in Chicago, IL. The company's presentation is scheduled to begin at 8:35 AM CT. The presentation is webcast and can be accessed through the con.
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
Positiv
The Motley Fool
vor 2 Monaten
Why UFP Technologies Stock Is Skyrocketing Today
UFP Technologies grew sales and adjusted earnings per share by 15% and 17% in the second quarter. This was even though its largest product category -- robotic surgery drapes -- was largely flat.
Why UFP Technologies Stock Is Skyrocketing Today
Positiv
MarketBeat
vor 2 Monaten
UFP Technologies Q2 Earnings Call Highlights
UFP Technologies NASDAQ: UFPT reported second-quarter 2026 sales growth of 15.1% to $174 million, supported by broad-based demand across its medical technology portfolio, while adjusted earnings per share rose 16.8% to a company-record $2.92.
UFP Technologies Q2 Earnings Call Highlights
Neutral
Seeking Alpha
vor 2 Monaten
UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript
UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript
UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript
Positiv
Zacks Investment Research
vor 2 Monaten
UFP Technologies (UFPT) Beats Q2 Earnings and Revenue Estimates
UFP Technologies (UFPT) came out with quarterly earnings of $2.92 per share, beating the Zacks Consensus Estimate of $2.51 per share. This compares to earnings of $2.5 per share a year ago.
UFP Technologies (UFPT) Beats Q2 Earnings and Revenue Estimates
Neutral
Business Wire
vor 2 Monaten
UFP Technologies Announces Record Q2 Results
NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.9 million for its second quarter ended June 30, 2026, 21.4% higher than net income of $17.2 million for the second quarter of 2025. Net sales for the quarter ended June 30, 2026 were $174.0 million, 15.1%.
UFP Technologies Announces Record Q2 Results
Kursdiagramme mit Lightweight Charts™ umgesetzt